Pamela N. Munster

MD

Medical oncologist

  • Education

    University of Bern, 1989

  • Residencies

    Indiana University School of Medicine, Internal Medicine, 1996

  • Fellowships

    Memorial Sloan-Kettering Cancer Center, Hematology-Oncology, 2000

  • Academic Title

    Professor

  • Languages

    French

    German

    Italian

Conditions I specialize in

Where I see patients (3)

    My reviews

    4.8

    Overall Experience
    125 Ratings
    About our process
    Jul 05, 2023
    Both the fellow and Doctor were great. We learned a lot from the visit and will follow up with them.
    Jun 24, 2023
    We are working on how best to communicate given we are both sensitive to perceived criticism. However I greatly appreciate that she spoke to me as an adult and keeps me actively involved in the treatment plan. We are working on complex issues. Dr. Munster and her team are very willing to dive in to come up with the best course of treatment and do not hand wave symptoms that have serious Impact on my life and health.
    May 13, 2023
    Excellent consultation.
    Apr 22, 2023
    I had a flare of a problem only marginally related to the issue I was there for listened to my issue and moved quickly to get it addressed. I had raised this issue with the relevant MDs in the previous weeks.
    Apr 06, 2023
    I love Dr. Munster. She is a superwoman. I went in with a concern about a potential divorce disability paper work and concern about working after 20 months of treatment (5 months of chemo 4 surgeries radiation and a twice a day chemo pill). I was also concerned about some recent exhaustion from the Verzenio and whether teaching would be too much for me right now. I Had called ahead to discuss disability paper work and the person whom I talked to seemed very confused and then did not seem to pass the correct information on to Dr. Munster. I probably should have asked more questions but felt like I was being a bit annoying I would like understanding about my concerns surrounding going back to work full time while raising kids alone while in active treatment while dealing with an extremely difficult situation at home. Dr. Munster is so thorough with the breast exams. She knows the anatomy so well. Whatever she says I trust 1000%. There is no one like her. She is the best at what she does. She knows everything and Is even better at PT than the awesome PTs. She did schedule an MRI and the slightest thought of recurrence keeps me up at night. The wait time for the MRI was 3 months. I called and emailed and I am grateful that Dr. Munster and her team helped me get it moved up. Now it's only a few weeks away. Still a bit far for my comfort levels. Hoping praying and believing it will be fine. Thank you for expediting the wait tone.
    Apr 05, 2023
    My PET/CT was ordered without contrast. Who placed the order? I was dosed with radiation yet the scan yielded little value. I don't have time to wait another 3 months before I get another scan. Alternative was an MRI which I am trying to get scheduled now.
    Mar 15, 2023
    Dr Munster explained possible future plans for my health in a way that was easy to understand.
    Feb 17, 2023
    Excellent care. Excellent service
    Jan 25, 2023
    Amazing care and a bright positive attitude and thoughtful approach.
    Jan 22, 2023
    Great experience very caring and hopefull
    Nov 14, 2022
    I could not ask for better care. So grateful
    Nov 11, 2022
    Dr Munster is remarkable I am lucky to be in her care
    Aug 12, 2022
    An amazing doctor and human.
    Aug 06, 2022
    I am so grateful for Dr. Munster's care!!!
    Jun 02, 2022
    Great care provider
    May 25, 2022
    Bad experiences. The staff did a poor job by setting me an appointment. They should of have ask uf I was currently on chemo
    Mar 20, 2022
    Very good doctor. Very happy with the care I have received.
    Mar 04, 2022
    Dr Munster is the most awesome doctor ever
    Dec 08, 2021
    Dr.Munster was very good. She answered all my questions. I did not feel rushed. She spent sufficient time with me.
    Sep 24, 2021
    I am so blessed to have Dr. Munster as my oncologist. She is amazingly smart kind nice and a pleasure to be with. I am so lucky and grateful!
    Aug 27, 2021
    Top doctor and hospital.

    Selected research

    See all research
    Decorative Caduceus

    Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mut...

    Time to breast cancer (invasive or DCIS) will be compared between the two treatment arms using a stratified Cox proportional hazards regression model.

    Recruiting

    Decorative Caduceus

    Pilot Study of Pancreatic Cancer Screening

    Proportion of participants with an abnormal MRI finding will be reported as an event. An estimated event rate of 19% in participants with a strong family history (FH) of pancreatic cancer and 10% in those participants without a st...

    Recruiting

    Decorative Caduceus

    Combination Therapy in Cancers With Mutations in DNA Repair Genes

    The percentage of participants with treatment-emergent adverse events as classified and graded by the NCI Common Terminology Criteria for Adverse Events (CTCAE) version 5 will be reported

    Recruiting

    Decorative Caduceus

    Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Adv...

    Number of patients with adverse events and with serious adverse events including abnormal clinical observations, abnormal ECG parameters, abnormal laboratory assessments and abnormal vital signs that changed from baseline

    Recruiting

    Decorative Caduceus

    A Study of SGN-STNV in Advanced Solid Tumors

    To be summarized using descriptive statistics

    Recruiting

    Decorative Caduceus

    Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous R...

    ORR is defined as the percentage of participants who achieve a confirmed complete response ([CR]; disappearance of all target lesions) or partial response ([PR]: ≥30% decrease in the sum of diameters of target lesions) as assessed...

    Recruiting

    Decorative Caduceus

    Study to Evaluate D-1553 in Subjects With Solid Tumors

    Recruiting

    Decorative Caduceus

    Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors

    A dose limiting toxicity (DLT) will be defined as any predetermined adverse events occurring during Cycle 1 when association to therapy that is part of this study is related or possibly related

    Recruiting

    Decorative Caduceus

    A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combinat...

    Severity is determined according to National Cancer Institute Common Terminology Criteria for Adverse Events, Version 5.0 (NCI CTCAE v5.0)

    Recruiting

    Decorative Caduceus

    JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK ...

    Safety and tolerability assessed by adverse events (AEs) and serious adverse events (SAEs)

    Recruiting

    Contact me

    Share